UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7096) 7096
Book Chapter (66) 66
Magazine Article (8) 8
Streaming Video (6) 6
Book / eBook (4) 4
Dissertation (4) 4
Newspaper Article (3) 3
Publication (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5388) 5388
covid-19 (5320) 5320
humans (5183) 5183
life sciences & biomedicine (4976) 4976
sars-cov-2 (4934) 4934
pandemics (3723) 3723
coronaviruses (3629) 3629
severe acute respiratory syndrome coronavirus 2 (2461) 2461
severe acute respiratory syndrome (1568) 1568
betacoronavirus (1485) 1485
viral diseases (1313) 1313
female (1243) 1243
health aspects (1217) 1217
viruses (1209) 1209
male (1205) 1205
infections (1165) 1165
coronavirus infections - epidemiology (1085) 1085
pneumonia, viral - epidemiology (1083) 1083
animals (1075) 1075
coronavirus (891) 891
middle aged (860) 860
epidemics (856) 856
coronavirus infections - virology (848) 848
coronavirus infections - drug therapy (832) 832
review (824) 824
pneumonia, viral - virology (817) 817
disease transmission (805) 805
patients (778) 778
adult (772) 772
pneumonia, viral - drug therapy (762) 762
infectious diseases (734) 734
respiratory diseases (726) 726
antiviral agents - pharmacology (704) 704
biochemistry & molecular biology (696) 696
proteins (695) 695
covid‐19 (693) 693
public health (693) 693
mortality (681) 681
aged (673) 673
pharmacology & pharmacy (673) 673
vaccines (654) 654
antiviral agents (630) 630
pandemics - prevention & control (613) 613
immunology (610) 610
antiviral agents - therapeutic use (594) 594
betacoronavirus - drug effects (576) 576
coronavirus infections - prevention & control (569) 569
risk factors (568) 568
inflammation (560) 560
virology (552) 552
covid-19 - drug therapy (549) 549
medical research (544) 544
pneumonia, viral - prevention & control (529) 529
pneumonia (505) 505
analysis (494) 494
sars‐cov‐2 (491) 491
coronavirus infections - diagnosis (473) 473
pneumonia, viral - complications (472) 472
coronavirus infections - complications (471) 471
clinical trials (467) 467
viral infections (447) 447
covid-19 - virology (445) 445
general & internal medicine (445) 445
pneumonia, viral - diagnosis (432) 432
cytokines (429) 429
coronavirus infections - immunology (428) 428
covid-19 - epidemiology (427) 427
medicine, research & experimental (423) 423
research & experimental medicine (422) 422
coronavirus infections - therapy (407) 407
microbiology (401) 401
pneumonia, viral - therapy (399) 399
medicine, general & internal (394) 394
pneumonia, viral - immunology (390) 390
epidemiology (381) 381
betacoronavirus - pathogenicity (367) 367
middle east respiratory syndrome (366) 366
physical sciences (362) 362
sars-cov-2 - drug effects (362) 362
enzymes (357) 357
science & technology - other topics (356) 356
sars (347) 347
angiotensin-converting enzyme 2 (346) 346
betacoronavirus - isolation & purification (342) 342
medicine, experimental (335) 335
coronavirus infections (334) 334
cell biology (331) 331
retrospective studies (330) 330
sars virus - drug effects (320) 320
abridged index medicus (319) 319
influenza (319) 319
antibodies (318) 318
multidisciplinary sciences (309) 309
comorbidity (305) 305
immune response (303) 303
chemistry (302) 302
angiotensin (300) 300
betacoronavirus - immunology (300) 300
betacoronavirus - physiology (296) 296
laboratories (295) 295
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7164) 7164
Chinese (20) 20
Spanish (12) 12
French (8) 8
Italian (8) 8
Russian (8) 8
Japanese (7) 7
Portuguese (6) 6
German (5) 5
Hungarian (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature reviews. Immunology, ISSN 1474-1733, 10/2020, Volume 20, Issue 10, pp. 633 - 643
Life Sciences & Biomedicine | Immunology | Science & Technology | Betacoronavirus - pathogenicity | SARS Virus - immunology | Antibodies, Neutralizing - administration & dosage | Pandemics | Severe Acute Respiratory Syndrome - virology | Antibodies, Monoclonal - biosynthesis | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Antibodies, Monoclonal - adverse effects | Severe Acute Respiratory Syndrome - immunology | Host-Pathogen Interactions - drug effects | Receptors, IgG - antagonists & inhibitors | Virus Internalization - drug effects | Host-Pathogen Interactions - immunology | Betacoronavirus - immunology | COVID-19 | Leukocytes - immunology | Receptors, IgG - genetics | SARS-CoV-2 | Dengue - drug therapy | Dengue Virus - immunology | Dengue Virus - pathogenicity | Antibodies, Neutralizing - adverse effects | Antibody-Dependent Enhancement - drug effects | Dengue - immunology | Antibodies, Viral - administration & dosage | Antibodies, Viral - biosynthesis | Antibodies, Viral - adverse effects | Dengue Virus - drug effects | Signal Transduction | Betacoronavirus - drug effects | Gene Expression Regulation | SARS Virus - drug effects | Dengue - virology | Receptors, IgG - immunology | Severe Acute Respiratory Syndrome - drug therapy | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | SARS Virus - pathogenicity | Coronavirus Infections - virology | Antibodies, Monoclonal - administration & dosage | Antibodies, Neutralizing - biosynthesis | Leukocytes - virology | Leukocytes - drug effects | Pneumonia, Viral - virology | Infection | Virus diseases | Fc receptors | Antiviral agents | Immune response | Phosphoproteins | Analysis | Dengue viruses | Immunoglobulin G | B cells | Health aspects | Severe acute respiratory syndrome coronavirus 2 | Pathogenesis | Dengue fever | Dengue | Antibodies | Infections | Viral infections | Index Medicus
Journal Article
Nature reviews. Drug discovery, ISSN 1474-1776, 03/2020, Volume 19, Issue 3, pp. 149 - 150
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Betacoronavirus - pathogenicity | Recombinant Proteins - therapeutic use | Interferon-alpha - pharmacology | Alanine - therapeutic use | Hepatitis C - drug therapy | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Polyethylene Glycols - therapeutic use | COVID-19 | Alanine - analogs & derivatives | Protease Inhibitors - pharmacology | SARS-CoV-2 | SARS Virus - genetics | Nucleosides - pharmacology | Spike Glycoprotein, Coronavirus - drug effects | Influenza, Human - drug therapy | Protease Inhibitors - therapeutic use | Polyethylene Glycols - pharmacology | Nucleosides - therapeutic use | Antiviral Agents - therapeutic use | Betacoronavirus - drug effects | Interferon-alpha - therapeutic use | Middle East Respiratory Syndrome Coronavirus - drug effects | SARS Virus - drug effects | Drug Repositioning | Recombinant Proteins - pharmacology | Adenosine Monophosphate - therapeutic use | SARS Virus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - genetics | Adenosine Monophosphate - analogs & derivatives | Hepatitis B - drug therapy | HIV Infections - drug therapy | Betacoronavirus - genetics | Antiviral agents | Pharmacology, Experimental | Physiological aspects | Drug targeting | Genetic aspects | Research | Coronaviruses | Clinical trials | Index Medicus
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 07/2020, Volume 76, Issue 1, pp. 51 - 58
Journal Article
Trends in biotechnology (Regular ed.), ISSN 0167-7799, 09/2020, Volume 38, Issue 9, pp. 943 - 947
COVID-19 | innovation speed | vaccine development | regulation | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Betacoronavirus - pathogenicity | United States - epidemiology | Severe Acute Respiratory Syndrome - epidemiology | Hemorrhagic Fever, Ebola - prevention & control | Humans | Pandemics - prevention & control | Severe Acute Respiratory Syndrome - immunology | Middle East Respiratory Syndrome Coronavirus - immunology | Betacoronavirus - immunology | SARS-CoV-2 | Hemorrhagic Fever, Ebola - virology | Influenza, Human - virology | Zika Virus - pathogenicity | Ebola Vaccines - administration & dosage | Hemorrhagic Fever, Ebola - epidemiology | Coronavirus Infections - immunology | SARS Virus - pathogenicity | Viral Vaccines - administration & dosage | Coronavirus Infections - virology | Influenza Vaccines - biosynthesis | COVID-19 Vaccines | Government Regulation | Zika Virus Infection - immunology | Influenza, Human - prevention & control | Coronavirus Infections - prevention & control | Influenza A Virus, H1N1 Subtype - immunology | SARS Virus - immunology | Influenza Vaccines - administration & dosage | Severe Acute Respiratory Syndrome - virology | Ebolavirus - pathogenicity | Ebolavirus - immunology | Ebolavirus - drug effects | Zika Virus Infection - virology | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Global Health - trends | Hemorrhagic Fever, Ebola - immunology | Zika Virus Infection - prevention & control | Influenza A Virus, H1N1 Subtype - genetics | Ebola Vaccines - biosynthesis | Viral Vaccines - biosynthesis | Zika Virus - immunology | Betacoronavirus - drug effects | Europe - epidemiology | Middle East Respiratory Syndrome Coronavirus - drug effects | SARS Virus - drug effects | Influenza, Human - epidemiology | Zika Virus - drug effects | Drug Approval - organization & administration | Pneumonia, Viral - immunology | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Severe Acute Respiratory Syndrome - prevention & control | Zika Virus Infection - epidemiology | Pneumonia, Viral - prevention & control | Pneumonia, Viral - virology | Influenza, Human - immunology | Business schools | Vaccines | Health aspects | Nanotechnology | Vector-borne diseases | Epidemics | Pandemics | Swine flu | Viral diseases | Outbreaks | Viruses | Coronaviruses | Epidemiology | Index Medicus
Journal Article
Virus research, ISSN 0168-1702, 02/2018, Volume 246, pp. 28 - 34
Nidoviruses | Replication organelles | K22 | Double membrane vesicles | Antiviral drug | Life Sciences & Biomedicine | Science & Technology | Virology | Arterivirus - drug effects | Torovirus - drug effects | Epithelial Cells - drug effects | Equartevirus - metabolism | Coronaviridae - metabolism | Porcine respiratory and reproductive syndrome virus - drug effects | Porcine respiratory and reproductive syndrome virus - genetics | RNA, Double-Stranded - antagonists & inhibitors | Porcine respiratory and reproductive syndrome virus - metabolism | RNA, Viral - antagonists & inhibitors | Arterivirus - growth & development | RNA, Viral - genetics | Piperidines - pharmacology | Torovirus - genetics | Arterivirus - metabolism | Mesocricetus | Equartevirus - genetics | Benzamides - pharmacology | Coronaviridae - growth & development | Coronaviridae - genetics | Porcine respiratory and reproductive syndrome virus - growth & development | Cell Line | Virus Replication - drug effects | Antiviral Agents - pharmacology | Chlorocebus aethiops | Torovirus - metabolism | RNA, Viral - biosynthesis | Torovirus - growth & development | RNA, Double-Stranded - biosynthesis | Coronaviridae - drug effects | Equartevirus - drug effects | Carps | Equartevirus - growth & development | Arterivirus - genetics | Animals | Epithelial Cells - virology | RNA, Double-Stranded - genetics | Antiviral agents | Hemorrhagic fever | Synthesis | RNA | Microbiology | Analysis | Severe acute respiratory syndrome | Monkeys | Coronaviruses | Genetic transcription | Hepatitis C | Index Medicus | dsRNA, double-stranded RNA | HCV, hepatitis C virus | ICTV, International Committee for the Taxonomy of Viruses | UTR, untranslated region | CAVV, Cavally virus | PEDV, porcine epidemic diarrhea virus | SARS-CoV, severe acute respiratory syndrome coronavirus | CM, convoluted membrane | PRRSV, porcine reproductive and respiratory syndrome virus | IBV, avian infectious bronchitis virus | NS5A, non-structural protein 5A | nsp6, non-structural protein 6 | DNA, deoxyribonucleic acid | TCID, tissue culture infective dose | FCoV, feline coronavirus | mRNA, messenger RNA | DMV, double membrane vesicles | RNA, ribonucleic acid | ORF, open reading frame | SHFV, simian haemorrhagic fever virus | RTC, replication-transcription complex | RVN, reticulo-vesicular network | EToV, equine torovirus | MERS-CoV, Middle East respiratory syndrome coronavirus | DMEM, Dulbecco’s modified Eagle’s medium | EAV, equine arteritis virus | FBS, foetal bovine serum | DMSO, dimethyl sulfoxide | ER, endoplasmic reticulum
Journal Article